
### [NCIT:C3680](http://purl.obolibrary.org/obo/NCIT_C3680)
**Label:** Cribriform Carcinoma

**Subclasses:** [NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern), [NCIT:C96891](http://purl.obolibrary.org/obo/NCIT_C96891) (Gallbladder Cribriform Carcinoma), [NCIT:C5138](http://purl.obolibrary.org/obo/NCIT_C5138) (Intraductal Cribriform Breast Adenocarcinoma), [NCIT:C96488](http://purl.obolibrary.org/obo/NCIT_C96488) (Colorectal Cribriform Comedo-Type Adenocarcinoma), [NCIT:C96489](http://purl.obolibrary.org/obo/NCIT_C96489) (Colon Cribriform Comedo-Type Adenocarcinoma), [NCIT:C96490](http://purl.obolibrary.org/obo/NCIT_C96490) (Rectal Cribriform Comedo-Type Adenocarcinoma), [NCIT:C5904](http://purl.obolibrary.org/obo/NCIT_C5904) (Salivary Duct Carcinoma), [NCIT:C62192](http://purl.obolibrary.org/obo/NCIT_C62192) (Salivary Gland Low Grade Cribriform Cystadenocarcinoma), [NCIT:C5142](http://purl.obolibrary.org/obo/NCIT_C5142) (Invasive Cribriform Breast Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C38721](http://purl.obolibrary.org/obo/NCIT_C38721) (Nuclear Pleomorphism) 55.56%
- [NCIT:C36104](http://purl.obolibrary.org/obo/NCIT_C36104) (Aggressive Clinical Course) 55.56%
- [NCIT:C36103](http://purl.obolibrary.org/obo/NCIT_C36103) (Rapidly Enlarging Mass) 55.56%
- Thing 52.44%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 49.48%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 48.28%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) 40.91%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 40.91%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 40.91%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 40.91%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 40.91%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 40.91%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 40.91%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 40.91%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 40.91%


